A study at Umeå University, Sweden, provides new clues in the understanding of how antibiotic resistance spreads.
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in PTPN2.